Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse.
Bortezomib is the first proteasome inhibitor with significant antineoplastic activity for the treatment of relapsed/refractory multiple myeloma as well as other hematological and solid neoplasms. Peripheral neurological complications manifesting with paresthesias, burning sensations, dysesthesias, numbness, sensory loss, reduced proprioception and vibratory sensitivity are among the major limiting side effects associated with bortezomib therapy. Although bortezomib-induced painful peripheral neuropathy is clinically easy to diagnose and reliable models are available, its pathophysiology remains partly unclear. In this study we used well-characterized immune-competent and immune-compromised mouse models of bortezomib-induced painful peripheral neuropathy. To characterize the drug-induced pathological changes in the peripheral nervous system, we examined the involvement of spinal cord neuronal function in the development of neuropathic pain and investigated the relevance of the immune response in painful peripheral neuropathy induced by bortezomib. We found that bortezomib treatment induced morphological changes in the spinal cord, dorsal roots, dorsal root ganglia (DRG) and peripheral nerves. Neurophysiological abnormalities and specific functional alterations in Aδ and C fibers were also observed in peripheral nerve fibers. Mice developed mechanical allodynia and functional abnormalities of wide dynamic range neurons in the dorsal horn of spinal cord. Bortezomib induced increased expression of the neuronal stress marker activating transcription factor-3 in most DRG. Moreover, the immunodeficient animals treated with bortezomib developed a painful peripheral neuropathy with the same features observed in the immunocompetent mice. In conclusion, this study extends the knowledge of the sites of damage induced in the nervous system by bortezomib administration. Moreover, a selective functional vulnerability of peripheral nerve fiber subpopulations was found as well as a change in the electrical activity of wide dynamic range neurons of dorsal horn of spinal cord. Finally, the immune response is not a key factor in the development of morphological and functional damage induced by bortezomib in the peripheral nervous system.
Department of Surgery and Translational Medicine, University of Milan Bicocca, Monza, Italy.
Valentina A
VA
Carozzi
Cynthia L
CL
Renn
Michela
M
Bardini
Grazia
G
Fazio
Alessia
A
Chiorazzi
Cristina
C
Meregalli
Norberto
N
Oggioni
Kathleen
K
Shanks
Marina
M
Quartu
Maria Pina
MP
Serra
Barbara
B
Sala
Guido
G
Cavaletti
Susan G
SG
Dorsey
D051700:Activating Transcription Factor 3 / Q000235:genetics / Q000378:metabolism; D000818:Animals; D001897:Boronic Acids / Q000494:pharmacology*; D000069286:Bortezomib; D004594:Electrophysiology / Q000379:methods*; D005260:Female; D051379:Mice; D008807:Mice, Inbred BALB C; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000378:metabolism; D011719:Pyrazines / Q000494:pharmacology*
D051700:Activating Transcription Factor 3; C103002:Atf3 protein, mouse; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib